瑞珍斯生物 RGNX
$7.62 +$0.24 (+3.25%)
休市 · Nov 6, 10:00 pm ET · 最新盘后价 $7.62 0.00%
开盘$7.33
昨收$7.38
当日区间$7.33 – $7.87
成交量1.19M
市值$503.85M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$108.02M+405.7% YoY
营业利润$29.26M+146.2% YoY
净利润$22.71M+132.0% YoY
摊薄每股收益$0.43+131.2% YoY
自由现金流-$63.00M-26.7% YoY
经营现金流-$62.24M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率86.4%
营业利润率-94.1%
净利率-112.6%
净资产收益率-137.6%
资产收益率-40.6%
投入资本回报率-71.5%
流动比率2.86
负债/资产比率81.4%
现金及投资$105.52M
总负债$61.60M
净现金（净负债）$43.92M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $108.02M | $6.39M | $170.44M | $30.34M | $29.73M |
| 营业总收入 | $108.02M | $6.39M | $170.44M | $30.34M | $29.73M |
| 营业成本 | $1.04M | $11.07M | $20.30M | $5.93M | $5.73M |
| 毛利润 | $106.98M | -$4.68M | $150.14M | $24.41M | $24.01M |
| 营业费用 | $77.71M | $78.68M | $311.34M | $82.05M | $76.42M |
| 销售及管理费用 | $21.62M | $21.31M | $82.86M | $22.38M | $20.25M |
| -管理费用 | $21.62M | $21.31M | $82.86M | $22.38M | $20.25M |
| 研发费用 | $56.09M | $57.34M | $228.30M | $59.61M | $56.10M |
| 其他营业费用 | $12,000.00 | $36,000.00 | $179,000.00 | $54,000.00 | $65,000.00 |
| 营业利润 | $29.26M | -$83.36M | -$161.20M | -$57.64M | -$52.41M |
| 非经营性利息净收入（支出） | -$7.78M | -$8.69M | -$44.93M | -$12.26M | -$13.15M |
| 非经营性利息收入 | $17,000.00 | $16,000.00 | $83,000.00 | $18,000.00 | $19,000.00 |
| 非经营性利息支出 | $7.79M | $8.71M | $45.01M | $12.28M | $13.17M |
| 其他收入（支出） | $1.22M | $2.00M | $12.25M | $2.75M | $3.62M |
| 证券出售收益 | $1.22M | $2.00M | $12.25M | $2.75M | $3.62M |
| 税前利润 | $22.71M | -$90.05M | -$193.88M | -$67.15M | -$61.94M |
| 净利润 | $22.71M | -$90.05M | -$193.88M | -$67.15M | -$61.94M |
| 持续经营利润 | $22.71M | -$90.05M | -$193.88M | -$67.15M | -$61.94M |
| 归属母公司净利润 | $22.71M | -$90.05M | -$193.88M | -$67.15M | -$61.94M |
| 归属普通股股东净利润 | $22.71M | -$90.05M | -$193.88M | -$67.15M | -$61.94M |
| 基本每股收益 | $0.43 | -$1.72 | -$3.76 | -$1.30 | -$1.20 |
| 摊薄每股收益 | $0.43 | -$1.72 | -$3.76 | -$1.30 | -$1.20 |
| 资产减值损失 | – | – | $0.00 | – | – |
| 特殊收益（费用） | – | – | $0.00 | $0.00 | $0.00 |
| -减：资本性资产减值 | – | – | $0.00 | $0.00 | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $386.62M | $341.89M | $453.03M | $453.03M | $525.20M |
| 流动资产合计 | $236.16M | $186.52M | $281.28M | $281.28M | $331.97M |
| 现金及现金等价物与短期投资 | $105.52M | $150.49M | $230.07M | $230.07M | $274.21M |
| -现金及现金等价物 | $36.49M | $15.23M | $34.47M | $34.47M | $58.80M |
| -短期投资 | $69.03M | $135.26M | $195.60M | $195.60M | $215.40M |
| 应收款 | $107.10M | $10.94M | $27.38M | $27.38M | $26.47M |
| -应收账款 | $100.39M | $2.80M | $557,000.00 | $557,000.00 | $20,000.00 |
| -应计应收利息 | $348,000.00 | $902,000.00 | $1.00M | $1.00M | $1.12M |
| -其他应收款 | $6.37M | $7.24M | $25.82M | $25.82M | $25.33M |
| 预付资产 | $11.90M | $11.54M | $11.93M | $11.93M | $12.94M |
| 受限现金 | $225,000.00 | – | – | – | – |
| 其他流动资产 | $11.41M | $13.54M | $11.90M | $11.90M | $18.35M |
| 非流动资产合计 | $150.46M | $155.38M | $171.75M | $171.75M | $193.24M |
| 固定资产净值 | $142.32M | $147.42M | $152.01M | $152.01M | $156.34M |
| -固定资产原值 | $236.25M | $238.42M | $239.20M | $239.20M | $239.87M |
| -累计折旧 | -$93.93M | -$91.01M | -$87.19M | -$87.19M | -$83.54M |
| 投资及预付款 | $0.00 | $0.00 | $10.79M | $10.79M | $27.84M |
| 一年以上应收账款 | $435,000.00 | $420,000.00 | $2.31M | $2.31M | $2.77M |
| 其他非流动资产 | $7.71M | $7.54M | $6.64M | $6.64M | $6.30M |
| 负债合计 | $314.85M | $320.81M | $350.30M | $350.30M | $363.75M |
| 流动负债合计 | $82.62M | $71.11M | $118.10M | $118.10M | $124.57M |
| 应付款 | $15.55M | $21.21M | $21.36M | $21.36M | $22.27M |
| -应付账款 | $15.55M | $21.21M | $21.36M | $21.36M | $22.27M |
| 一年内应计费用 | $10.11M | $12.53M | $20.97M | $20.97M | $23.24M |
| 短期债务及融资租赁负债 | $7.36M | $7.87M | $8.29M | $8.29M | $9.07M |
| -一年内到期融资租赁负债 | $7.36M | $7.87M | $8.29M | $8.29M | $9.07M |
| 一年内递延负债 | $9.88M | $5.92M | $10.45M | $10.45M | $13.20M |
| 其他流动负债 | $26.77M | $14.23M | $39.61M | $39.61M | $41.72M |
| 非流动负债合计 | $232.23M | $249.70M | $232.20M | $232.20M | $239.18M |
| 长期债务及融资租赁负债 | $61.60M | $63.20M | $65.22M | $65.22M | $67.43M |
| -长期融资租赁负债 | $61.60M | $63.20M | $65.22M | $65.22M | $67.43M |
| 一年以上递延负债 | $15.40M | $22.78M | $18.94M | $18.94M | $21.19M |
| 其他非流动负债 | $155.23M | $163.73M | $148.05M | $148.05M | $150.56M |
| 股东权益合计 | $71.77M | $21.08M | $102.73M | $102.73M | $161.45M |
| 股东权益 | $71.77M | $21.08M | $102.73M | $102.73M | $161.45M |
| 股本 | $5,000.00 | $5,000.00 | $5,000.00 | $5,000.00 | $5,000.00 |
| -普通股 | $5,000.00 | $5,000.00 | $5,000.00 | $5,000.00 | $5,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $1.27B | $1.24B | $1.23B | $1.23B | $1.22B |
| 留存收益 | -$1.19B | -$1.22B | -$1.13B | -$1.13B | -$1.06B |
| 不影响留存收益的损益 | -$875,000.00 | -$870,000.00 | -$687,000.00 | -$687,000.00 | -$652,000.00 |
| -可供出售证券 | – | – | $10.79M | $10.79M | $27.84M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$62.24M | -$76.19M | -$123.96M | -$52.29M | -$55.96M |
| 持续经营经营活动现金流净额 | -$62.24M | -$76.19M | -$123.96M | -$52.29M | -$55.96M |
| 持续经营净利润 | $22.71M | -$90.05M | -$193.88M | -$67.15M | -$61.94M |
| 折旧、折耗与摊销 | $3.76M | $3.86M | $15.62M | $3.87M | $3.89M |
| 其他非现金项目 | $5.54M | $2.89M | $13.50M | $5.64M | $7.78M |
| 营运资金变动 | -$103.28M | -$1.50M | $11.78M | -$1.80M | -$10.37M |
| -应收款变动 | -$96.71M | $18.25M | -$7.66M | -$561,000.00 | -$6.31M |
| -预付资产变动 | -$361,000.00 | $384,000.00 | -$2.86M | $1.02M | -$2.17M |
| -应付账款及应计费用变动 | -$4.12M | -$16.39M | -$2.06M | -$1.82M | $3.45M |
| -其他流动资产变动 | $3.57M | -$509,000.00 | $6.70M | $7.56M | -$699,000.00 |
| -其他流动负债变动 | -$2.25M | -$2.54M | -$11.62M | -$3.02M | -$1.24M |
| -其他营运资金变动 | -$3.41M | -$700,000.00 | $29.28M | -$4.99M | -$3.40M |
| 投资活动现金流净额 | $65.93M | $70.59M | -$15.87M | $37.54M | $42.29M |
| 持续经营投资活动现金流净额 | $65.93M | $70.59M | -$15.87M | $37.54M | $42.29M |
| 固定资产购置及出售净额 | -$760,000.00 | -$1.24M | -$2.41M | -$508,000.00 | -$491,000.00 |
| 投资购置及出售净额 | $66.69M | $71.82M | -$13.45M | $38.05M | $42.78M |
| 筹资活动现金流 | $17.57M | -$13.64M | $116.77M | -$9.58M | -$7.08M |
| 持续经营筹资活动现金流净额 | $17.57M | -$13.64M | $116.77M | -$9.58M | -$7.08M |
| 普通股发行净额 | $19.50M | $648,000.00 | $1.05M | $0.00 | $741,000.00 |
| 股票期权行使所得 | $51,000.00 | $146,000.00 | $318,000.00 | $90,000.00 | $0.00 |
| 其他筹资费用净额 | -$1.98M | -$14.43M | -$29.09M | -$9.67M | -$7.79M |
| 期末现金余额 | $38.52M | $17.26M | $36.50M | $36.50M | $60.83M |
| 现金净变动 | $21.26M | -$19.24M | -$23.06M | -$24.34M | -$20.76M |
| 期初现金余额 | $17.26M | $36.50M | $59.56M | $60.83M | $81.59M |
| 自由现金流 | -$63.00M | -$77.42M | -$126.38M | -$52.80M | -$56.45M |
| 持续经营损益 | – | – | -$62,000.00 | $0.00 | – |
| 债务发行及偿还净额 | – | – | $144.49M | $0.00 | -$33,000.00 |
暂无评论——快来第一个聊聊 RGNX。
登录后参与讨论。